← Leaderboards
Norton P Peet
Microbiotix, Inc
$3,225,521
Attributed
$3,225,521
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $721.5K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,225,521 · 4
By mechanism
R43$3,225,521 · 4
Top collaborators
No co-investigators on record.
Most similar at Microbiotix, Inc
Same institution · by research overlap
- Terry L Bowlin$33,687,170
- John D Williams$1,382,643
Others in their field
Top investigators on “Timeline”
- Jeffrey P Krischer · University Of South Florida$207,465,530
- Praduman Jain · Vignet, Inc.$102,576,382
- Richard A Gibbs · Baylor College Of Medicine$96,893,290
- Sumithra Jay Mandrekar · Mayo Clinic Rochester$58,838,304
- David Heimbrook · Leidos Biomedical Research, Inc.$57,703,445
- Mark Marino · Venturewell$49,985,567
Research focus
TimelineBioterrorismLungStructureDrug DesignIn VivoIn VitroLeadPermeabilitySmall MoleculePropertyBaseDrug KineticsDesignInhibitory Concentration 50CellsBiodefenseAntidotesEnzymesEnzyme Inhibitor DrugsEnzyme InhibitorsExhibitsEnvironmental Air FlowDose
Grant awards (8)
Carbocyclic nucleosides as therapeutics for Ebola infections$300,000
R43 · FY2010 · AI · contact PI
Carbocyclic nucleosides as therapeutics for Ebola infections$299,158
R43 · FY2009 · AI · contact PI
Inhibition of Ebola Virus Infection with Cathepsin L Inhibitors$300,000
R43 · FY2008 · AI · contact PI
Quinoline-Based Inhibitors of Botulinum Neurotoxin A$294,218
R43 · FY2008 · AI · contact PI
Inhibition of Ebola Virus Infection with Cathepsin L Inhibitors$300,000
R43 · FY2007 · AI · contact PI
Quinoline-Based Inhibitors of Botulinum Neurotoxin A$294,218
R43 · FY2007 · AI · contact PI
Small Molecule Inhibitors of Anthrax Lethal Factor$716,448
R43 · FY2006 · AI · contact PI
Small Molecule Inhibitors of Anthrax Lethal Factor$721,479
R43 · FY2005 · AI